Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04805073 · ClinicalTrials.gov registry record · Phase 4
Treatment of Pruritus With Intramuscular Promethazine
A Phase 4 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
NCT04805073 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 72 participants.
The verdict
NCT04805073, a Phase 4 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
Study Summary
Neuraxial narcotics are commonly used in obstetric patients for cesarean delivery to help with pain control over the first 24 hours after the surgery. The aim is to evaluate effectiveness of promethazine (IMP) treatment of intrathecal morphine induced pruritus (ITIMIP). A treatment for ITMIP, other than naloxone, will allow for increased use of intrathecal narcotics and decrease the use of systemic opioids in the initial post-operative period.
Interventions
- DRUG Placebo
- DRUG Promethazine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-08-09 |
| Est. Completion | 2024-05-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04805073
The ClinicalTrials.gov registry entry for NCT04805073 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04805073 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04805073 about?
NCT04805073 is a clinical study titled "Treatment of Pruritus With Intramuscular Promethazine". Neuraxial narcotics are commonly used in obstetric patients for cesarean delivery to help with pain control over the first 24 hours after the surgery. The aim is to evaluate effectiveness of promethazine (IMP) treatment of intrathecal morphine induced pruritus (ITIMIP). A treatment for ITMIP, other ...
What is the current status of trial NCT04805073?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2021-08-09. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT04805073?
The interventions under investigation include: Placebo (DRUG), Promethazine (DRUG).
Who is sponsoring clinical trial NCT04805073?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.